Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation - Trial NCT06416969
Access comprehensive clinical trial information for NCT06416969 through Pure Global AI's free database. This Phase 1 trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Obesity. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mayo Clinic
Timeline & Enrollment
Phase 1
May 01, 2024
Apr 01, 2027
Primary Outcome
Free Fatty Acid (FFA) release from femoral, splanchnic and upper body subcutaneous adipose tissue
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to
 factors that turn on fat cells the same way as people who don't have excessive weight.
 Researchers are trying to understand why fat tissue responds differently in people with
 different body types.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06416969
Non-Device Trial